The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 05, 2016

Filed:

Jan. 28, 2009
Applicants:

Thomas Kramps, Tübingen, DE;

Söhnke Voss, Tübingen, DE;

Jochen Probst, Wolfschlugen, DE;

Ingmar Hoerr, Tübingen, DE;

Inventors:

Thomas Kramps, Tübingen, DE;

Söhnke Voss, Tübingen, DE;

Jochen Probst, Wolfschlugen, DE;

Ingmar Hoerr, Tübingen, DE;

Assignee:

CureVac AG, Tübingen, DE;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07H 21/02 (2006.01); A61K 39/00 (2006.01); A61K 39/39 (2006.01); A61P 37/04 (2006.01); C07H 21/00 (2006.01); C12N 15/117 (2010.01);
U.S. Cl.
CPC ...
A61K 39/39 (2013.01); C07H 21/00 (2013.01); A61K 2039/55561 (2013.01); C12N 15/117 (2013.01); C12N 2310/17 (2013.01);
Abstract

The present invention relates to nucleic acids of the general formula (I): (NGXGN)and derivatives thereof as an immunostimulating agent/adjuvant and to compositions containing same, optionally comprising an additional adjuvant. The present invention furthermore relates to a pharmaceutical composition or to a vaccine, each containing nucleic acids of formula (I) above and/or derivatives thereof as an immunostimulating agent, and optionally at least one additional pharmaceutically active component, e.g. an antigenic agent. The present invention relates likewise to the use of the pharmaceutical composition or of the vaccine for the treatment of cancer diseases, infectious diseases, allergies and autoimmune diseases etc. Likewise, the present invention includes the use of nucleic acids of the general formula (I): (NGXGN)and/or derivatives thereof for the preparation of a pharmaceutical composition for the treatment of such diseases.


Find Patent Forward Citations

Loading…